However, the role of KCNQ channels in periadventitial vasoregulation is largely unknown. We tested the hypothesis that KCNQ channels play a major role in the paracrine control of vascular tone of peripheral skeletal muscle arteries by perivascular adipose tissue in rats. We tested therapeutic targeting of KCNQ channels in the SHR model of impaired periadventitial vascular regulation and replicated our findings in another model of increased peripheral arterial resistance and systemic arterial hypertension, namely the NZO mouse model.
Methods
All of the methods are described in detail in the online-only Data Supplement.
Isometric Contractions of Rat Vessels
The investigation conforms with the Guide for the Care and Use of Laboratory Animals published by the National Institutes of Health (publication No. 85-23, revised 1996) . Approval was granted by local review boards. Male Wistar or SHR rats were killed under ether narcosis. Isometric contraction of Gracilis muscle arteries was measured, whereby perivascular fat and connective tissue were either removed ([-] fat) or left intact ([+] fat; Figure 1A ).
1,2,4,10
The Gracilis muscle arteries were stretched to their optimal lumen diameter 24 and studied in standard physiological salt solution oxygenated with carbogen.
RT-Polymerase Chain Reaction
Total RNA was isolated using the RNeasy Mini Kit with a protocol closely resembling the manufacturer's description. The resulting RNA preparation was checked for purity, and RNA was reverse transcribed with random primers. Aliquots of the resulting cDNA were used for the quantitative reverse transcription-polymerase chain reaction (PCR) using the SYBR Green Jump Start Taq Ready Mix. For comparison of channel expression between SHRs and Wistar rats, the ΔΔ-method was used. 25 For demonstration of channel expression within Wistar rats, SYBR Green values of the individual KCNQ channel were normalized to GAPDH. Qualitative RT-PCR was used to demonstrate KCNQ gene expression in ethidium bromide gels.
Membrane Potential Recordings
Intracellular recordings of membrane potential in smooth muscle cells of intact arteries were made using microelectrodes filled with 3 mol/L KCl. The following criteria for acceptance of membrane potential recordings were used: (1) an abrupt change in membrane potential on cell penetration; (2) a constant electrode resistance when compared before, during, and after the measurement; (3) a stable reading of the membrane potential lasting >1 minute; and (4) no change in baseline when the electrode was removed.
Cell Isolation
A piece of a Gracilis muscle artery was placed into a microtube containing 1 mL of an isolation solution containing 0.6 mg/mL of papain and 1.2 mg/mL of DL-dithiothreitol for 20 minutes at 37 o C. Then, the artery was transferred into a microtube containing 1 mL of the isolation solution supplemented with 1.2 mg/mL of collagenase F, 1.0 mg/ mL of trypsin inhibitor, and 0.5 mg/mL of elastase for 12 minutes at 37 o C. Single cells were released by trituration with a polyethylene pipette into the experimental bath solution.
Patch-Clamp Recording
All of the experiments were performed at room temperature in the whole-cell mode. Patch pipettes had resistances of 2 to 5 megaohms. To reduce the contribution of BK channels, 10 -7 mol/L of iberiotoxin, a specific inhibitor of these channels, was added to the bath solution.
Blood Pressure Measurements
Systolic blood pressure (BP) in rats was measured using standard tailcuff methodology. 26, 27 Rats received vehicle (control), retigabine, or VRX0621688, respectively. We performed radiotelemetry on adult male C57Bl6 and NZO mice (34 weeks) as outlined elsewhere. 28 BP devices were implanted in mice. After 10 days, mice had recovered from surgery and exhibited regular diurnal rhythms of activity. Mice received vehicle (control), retigabine, VRX0621688, and VRX0530727.
Statistics
All of the values are given as mean±SEM. Paired and unpaired Student t tests, as well as 1-way or repeated-measures ANOVA, were used as appropriate. A value of P<0.05 was considered statistically significant; n represents the number of arteries tested. 
Results

Role of KCNQ Channels in Periadventitial Vasoregulation
Serotonin induced concentration-dependent contractions of Wistar rat Gracilis muscle arteries with and without perivascular adipose tissue. The concentration-response curve of (+) fat vessels was shifted to the right of the concentration-response curve of (−) fat vessels (n=6; Figure 1B) , demonstrating the anticontractile effect of perivascular fat. The resting membrane potential was more hyperpolarized in (+) fat vessels (−50.9±1.0 mV; n=5), compared with (−) fat vessels (−45.2±2.5 mV; n=4; P<0.01). The anticontractile effect of fat was also observed in endothelium-denuded preparations (n=6; Figure S1 , available in the online-only Data Supplement). There was no effect of fat on contractions induced by 30 to 120 mmol/L of KCl (n=20; Figure S2A ). The effects of fat were blocked by 2 mmol/L of 4-aminopyridine (n=6; Figure 1C ), an inhibitor of K v channels, 29 and by 30 µmol/L of XE991 (n=7; Figure 1D ) or 100 µmol/L of linopirdine (n=7; Figure 2A and 2B), which are KCNQ channel inhibitors. 30 In contrast, the effect of fat was not affected by 1 µmol/L of correolide (n=5; Figure 2C ) and 100 nmol/L of stromatoxin (n=7; Figure 2D ), specific inhibitors of K v 1 and K v 2 channels, respectively, 31, 32 as well as by blockers targeting other K + channels ( Figure S2B through S2D). In freshly isolated Wistar rat Gracilis muscle artery smooth muscle cells exposed to a holding potential of 0 mV, a noninactivating outward current was observed (n=6; Figure  3A and 3B). The KCNQ channel inhibitor XE991 reduced this current in a concentration-dependent manner with a halfmaximal effect at 9.6 µmol/L. The current was reduced by 75% at saturating concentrations (n=5-8; Figure 3A through 3C). Linopirdine produced a similar effect ( Figure 3B, inset) . In contrast, correolide did not affect the current ( Figure 3E ), and stromatoxin reduced the current only slightly ( Figure 3F ). Furthermore, XE991 at 30 µmol/L did not affect K v 1.5 channels expressed in Chinese hamster ovary cells (Figure S3A ), the predominant non-KCNQ K v channel in the vessels studied ( Figure S3B ). Moreover, 30 µmol/L of XE991 evoked a considerable depolarization in smooth muscle cells of intact vessels (n=4-5; Figure 3D ). This effect was associated with a small increase in basal tone but was not observed in response to 1 µmol/L of correolide or 100 nmol/L of stromatoxin (n=6; Figure S3C ). In addition, we detected mRNA of KCNQ 1, 3, 4, and 5 by reverse transcription-PCR (n=5) and quantitative reverse transcription-PCR (n=6) in intact rat Gracilis muscle arteries ( Figure 3G and 3H), with KCNQ4 being the dominant vascular channel subtype.
In (−) fat vessels, the anticontractile effect of perivascular fat was mimicked by application of the KCNQ channelopener retigabine. In the presence of 10 µmol/L of retigabine, (−) fat vessels showed contractions to serotonin similar to (+) fat vessels without retigabine (n=5; Figure S4A and S4B). Retigabine produced concentration-dependent vasorelaxation of serotonin-precontracted rat Gracilis muscle arteries in an endothelium-independent manner (n=5; data not shown), and its vasorelaxant effects were inhibited by high K + (60 mmol/L) containing bath solutions (n=5; Figure S4C ) and were reduced by XE991 (30 µmol/L; n=5; Figure S4D ).
KCNQ Channel Openers Improve the Diminished Anticontractile Effects of Perivascular Fat in SHRs
We have previously reported diminished anticontractile effects of perivascular fat in mesenteric arteries of SHRs, 6, 9 which can be explained by reduced expression of KCNQ4 channels ( Figure S5 ). In line, a reduced expression of vascular KCNQ4 channels contributing to increased contractility of aortas and mesenteric and renal arteries of SHRs was reported recently. 22, 23 However, Gracilis muscle arteries of SHRs exhibited normal KCNQ4 channel expression at the mRNA level (n=6; Figure 4A ). In addition, XE991 at a saturating concentration of 100 µmol/L (compare Figure 3C) Figure 4B and 4C; VRX0621238, n=4-6, data not shown; VRX0621688, n=4-6, Figure 4D ). Nevertheless, a loss of the anticontractile effects of perivascular fat was observed in Gracilis muscle arteries of SHRs (n=5; Figure  5A ). An interesting effect was observed after treatment of (+) fat SHR Gracilis muscle arteries with KCNQ channel openers. The serotonin concentration-response curves of (+) fat vessels in the presence of 30 µmol/L of VRX0530727 or 30 µmol/L of VRX0621688 were shifted to the right compared with (−) fat SHR vessels (n=5 each; Figure 5B and 5C), mimicking the normal situation of (+) fat and (−) fat in vessels of Wistar rats (compare Figure 1B) . The (−) fat SHR Gracilis muscle arteries showed preserved capabilities of relaxation in response to VRX0621688 ( Figure S6 ).
Systolic arterial BP was 190±3 mm Hg (n=5) and 130±2 mm Hg (n=5) in SHRs and Wistar rats, respectively Figure 5D ).
Effects of KCNQ Channel Openers in NZO Mice
We previously reported diminished anticontractile effects of perivascular fat in mesenteric arteries of NZO mice, in which visceral obesity and body weight increase with age. 10 Retigabine at doses >15 mg/kg IP reduced mean arterial BP in normotensive control mice (n=4; Figure 6A ); heart rate was not affected by retigabine. VRX0530727 induced similar effects (data not shown). Thirty-four-week-old NZO mice showed markedly elevated BP; mean arterial BP was ≈140 mm Hg ( Figure 6B ). The most potent KCNQ channel opener, VRX0621688 (15 mg/kg IP), reduced mean arterial BP by ≈10 mm Hg (n=5; Figure 6B ) without affecting heart rate. Retigabine and VRX0530727 at this dose (15 mg/kg IP each) were less effective (data not shown). The BP-lowering effects of the KCNQ channel opener were not inhibited by ganglionic blockade with hexamethonium (10 mg/kg; n=6; Figure 6C and 6D).
Discussion
Our study generated 4 novel findings. First, perivascular adipose tissue produces anticontractile effects in rat peripheral skeletal muscle arteries. These effects are not dependent on the endothelium. The KCNQ channel blockers XE991 and linopirdine inhibited the anticontractile effect of perivascular adipose tissue, suggesting that opening of smooth muscle KCNQ channels is involved. This suggestion is supported by the observation that correolide and stromatoxin did not affect the anticontractile effects of perivascular adipose tissue. Second, anticontractile effects of perivascular adipose tissue are reduced in rat peripheral skeletal muscle arteries of SHRs. Third, 3 chemically distinct KCNQ channel openers corrected the dysfunction of vascular regulation by perivascular adipose tissue and the reduced peripheral resistance in SHRs. Fourth, KCNQ channel opening decreases arterial BP in 2 models of chronic metabolic vascular diseases and hypertension, in SHR and NZO mice, without affecting heart rate and without involvement of autonomic ganglionic mechanisms. Our study is the first report on periadventitial regulation of peripheral skeletal muscle arteries by perivascular adipose tissue. The paracrine vasoregulation by perivascular adipose tissue is an important mechanism to control vascular tone and vascular homeostasis in visceral arteries. 3 This vasoregulation occurs in different visceral vascular beds and species, including rats, 1-4,6,7 mice, 10,11 pigs, 8 and humans. 5, 12, 13 The present study extends those findings to nonvisceral, peripheral skeletal muscle arteries. Both endothelium-independent 1,2,7,13 and endothelium-dependent 7,33 pathways have been suggested to play an important role. The nature of ADRF is largely unknown and may consist of several factors. ADRF is not adiponectin 10 and does not involve functional leptin receptors. 1 Lee et al 34 identified Ang 1-7 as perivascular derived relaxing factor; however, the effects of Ang 1-7 are mediated via both endothelium and BK channels and not by K v channels. 34 Both findings indicate that Ang 1-7 is not ADRF. Furthermore, methyl palmitate was reported as a novel candidate for periadventitial vasoregulation in the rat aorta. 17 Recent data indicate that H 2 S represents a candidate or modulator of ADRF. 15 ,16 H 2 S activates K v channels encoded by KCNQ genes, at least in visceral arteries such as rat aorta and mouse mesenteric arteries. 16 In the present study, we used rat Gracilis muscle arteries to study periadventitial vasoregulation in peripheral skeletal muscle arteries. We found a strong anticontractile effect of perivascular fat in these vessels. The effect was blocked by 4-AP, XE991, and linopirdine. The blocking effect of 4-AP 2,6,9,10 points to an additional role of K v channels in the anticontractile effect of perivascular fat, a nonselective block of native smooth muscle KCNQ channels by 4-AP or cooperative gating between K v /KCNQ channels by ADRF. 35 Of note, 4-AP does not discriminate between K v channel subfamilies and, more importantly, has off-target adverse effects, in particular, on intracellular pH. 36 Nevertheless, XE991 and linopirdine are currently the only available drugs to study the functional role of KCNQ channels. They have been successfully used to identify specific roles of KCNQ channels in the circulatory system. 30, 37 Of note, XE991 has been reported to reduce currents carried by heteromeric K v 1.2/K v 1.5 channels in HEK293 cells, 38 which have been suggested to be predominantly expressed in rat cerebral artery smooth muscle cells. 39 In contrast, our real-time PCR analysis of rat Gracilis muscle arteries 39, 40 In addition, the anticontractile effect of perivascular fat was also not influenced by blockers targeting other non-K v -type K + channels expressed in vascular smooth muscle cells. 29 Altogether, our results are consistent with the idea that XE991-and linopirdine-sensitive smooth muscle KCNQ-type K v channels mediate the anticontractile effect of perivascular fat in rat Gracilis muscle arteries. KCNQ channels have not been identified in isolated adipocytes by patch-clamp studies. In our experiments addressing this issue, RNA yield from Gracilis muscle artery adipose tissue was very low, and all of the probes contained endothelial NO synthase mRNA, indicating that small arterioles or capillaries were present in the samples, although all of the visible blood vessels had been removed. Thus, to achieve an isolation of pure adipocytes from perivascular adipose tissue, novel methods are required and need to be developed in separate studies. Nevertheless, the present results argue against a leading role of KCNQ channels in perivascular fat responsible for the anticontractile effects of perivascular adipose tissue in skeletal muscle and other arteries.
Importantly, we were able to identify KCNQ-type K v currents in smooth muscle cells of rat Gracilis muscle arteries using a similar protocol as developed previously for the isolation of KCNQ currents in other vascular smooth muscle cells. 21, 41 We identified a noninactivating, XE991-and linopirdine-sensitive outward current in smooth muscle cells of the preparation under study. The sensitivity of this current to XE991 showed striking similarities to heterologously expressed KCNQ4 channels, 42 which is, according to our data, the most prominent KCNQ channel isoform in rat Gracilis muscle arteries. This current was insensitive to correolide and only slightly sensitive to stromatoxin. Thus, our experimental protocol eliminated almost completely all of the other major K v currents observed in arterial smooth muscle, 39, 40 indicating successful isolation of KCNQ currents. Our data show that KCNQ4 channels are the most prominent isoform expressed in rat Gracilis arteries, followed by KCNQ5 and KCNQ1 channels. Expression of KCNQ2 and KCNQ3 channels was weak. A similar expression profile of KCNQ channels has been observed in mouse aorta and carotid and femoral arteries, that is, in large conduit systemic arteries. 19 Thus, the expression profile of KCNQ channels seems to be preserved in the systemic peripheral circulation compared with large, conduit vessels. In summary, our data suggest involvement of smooth muscle KCNQ channels in the anticontractile effects of perivascular fat in rat skeletal muscle arteries.
We and others have shown that periadventitial vasoregulation is diminished in different animal models of cardiovascular diseases. There is defective periadventitial regulation of arterial tone in SHRs, 6, 9 angiotensin II infusion-treated hypertensive rats, 14 and NZO mice. 10, 11 Similar disturbances have been reported in subcutaneous circulation of humans. 33 Our data suggest that KCNQ channels play a prominent role in the diminished ADRF-K v pathway in SHRs ( Figure  S7 ). Expression of all of the KCNQ channels subtypes, at least at the mRNA level, was not different between Gracilis muscle arteries of normotensive and hypertensive SHRs. However, KCNQ4 channel expression is reduced in mesenteric arteries, renal arteries, and aortas in hypertension ( Figure S5) . 22, 23 Together, these findings lead to the new suggestion that periadventitial dysregulation in arterial hypertension is caused by KCNQ channel downregulation (eg, KCNQ4) or diminished production of ADRF. In rat Gracilis muscle arteries, the diminished anticontractile effect of perivascular fat seems to reflect rather a decreased ADRF release (eg, H 2 S, Ang 1-7, and methyl palmitate) compared with altered expression or functional capability of KCNQ channels. Further studies are required to characterize ADRF candidates in this scenario. Nevertheless, the presented data support the novel concept that KCNQ channels are novel therapeutic targets to rescue impaired periadventitial vascular regulation and to reduce BP in systemic hypertension and metabolic syndrome ( Figure S7 ). In line with this suggestion, we observed that 3 chemically distinct KCNQ channel openers are potent vasodilators in both normotensive and hypertensive rats. Furthermore, we observed improvement of the diminished anticontractile effect of perivascular fat by KCNQ channel openers in systemic arteries and lowering of systemic BP in 2 animal models of impaired periadventitial function and associated hypertension. The effects were not inhibited by ganglionic blockade with hexamethonium. Because KCNQ4 channels are obviously not downregulated in Gracilis muscle arteries in hypertension, KCNQ channel openers may have a greater potential to lower BP by lowering peripheral resistance in the skeletal muscle circulation. Flupirtine decreases mean arterial BP and heart rate in anesthetized rats. 21 Together, these data indicate the therapeutic potential of KCNQ channel openers to restore diminished anticontractile effects of perivascular fat in SHRs. Our data also indicate that KCNQ channel openers can be used to improve regional blood flow in organs rich in visceral or perivascular fat, such as in the mesentery, coronary, renal, and skeletal muscle circulation.
In conclusion, our data show that skeletal muscle arteries exhibit periadventitial vasoregulation by perivascular adipose tissue with major involvement of XE991-and linopirdinesensitive KCNQ-type K v channels. We provide evidence that therapeutic targeting of KCNQ channels is an effective approach to improve impaired periadventitial regulation of arterial tone and peripheral resistance.
Perspectives
Only recently KCNQ channels have been identified in vascular smooth muscle. However, little is known about their functional role and involvement in vascular diseases.
We revealed an anticontractile role of perivascular adipose tissue in skeletal muscle arteries and show that XE991-and linopirdine-sensitive K v channels play a key role in this signaling pathway. Along with studies suggesting a contribution of vascular smooth muscle KCNQ channels to vasopressin-induced contractions 21 and β-adrenoceptormediated dilation of visceral arteries, 23 our study suggests an important role of KCNQ channels in the physiological regulation of the peripheral skeletal muscle circulatory system. Moreover, we propose the new concept that opening of KCNQ channels may be a potent therapeutic option for the treatment of periadventitial peripheral artery dysfunction and associated hypertension. Clearly, this novel translational aspect requires future studies comparing the potential of KCNQ channel openers with other vasodilators.
What Is New?
• We discovered the regulation of peripheral skeletal muscle arteries by perivascular adipose tissue.
• We identified the contribution of smooth muscle KCNQ-type Kv channels to this effect.
• We explored the role of KCNQ-type Kv channels as novel therapeutic targets to rescue periadventitial vascular dysfunction in hypertension.
What Is Relevant?
• Diminished periadventitial vasoregulation in the peripheral skeletal muscle circulation may contribute to vascular dysfunction in hypertension.
• KCNQ-type Kv channels in peripheral skeletal muscle arteries represent novel therapeutic targets to treat skeletal muscle vascular dysfunction and associated hypertension.
Summary
Our data suggest that KCNQ-type Kv channels play a pivotal role in periadventitial vasoregulation of peripheral skeletal muscle arteries. KCNQ channel opening is an effective mechanism to improve impaired periadventitial skeletal muscle vasoregulation and associated hypertension without involvement of autonomic ganglionic mechanisms.
Methods
Isometric contractions of rat vessels
The investigation conforms with the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No. 85-23, revised 1996). Approval was granted by local review boards. Male Wistar or spontaneously hypertensive (SHR) rats (200-300 g, 12-16 weeks, Charles River, Sulzfeld/Berlin Germany) were killed under ether narcosis. Isometric contraction of Gracilis arteries was measured using a Small Vessel Myograph (DMT 410M, Danish Myo Technology). The Gracilis arteries were excised, quickly transferred to cold (4 °C) oxygenated (95 % O 2 / 5 % CO 2 ) PSS, and then dissected into 2 mm rings whereby perivascular fat and connective tissue were either removed ((-) fat) or left intact ((+) fat) (Fig. 1A) 1-4 . Stripping the outer layer of the vessel with scissors and forceps was performed in a manner to remove the perivascular fat completely without damaging the adventitia. After equilibration, the Gracilis arteries were stretched to their optimal lumen diameter corresponding to 90 % of the passive diameter of the vessel at 100 mmHg and were allowed to stabilize for additional 15 minutes. The composition of PSS (in mM) was 120 NaCl, 4.5 KCl, 1.2 NaH 2 PO 4 , 26 NaHCO 3 , 1.0 MgSO 4 , 5.5 glucose, 1.6 CaCl 2 , 0.03 EDTA, 5.0 Hepes. The bath solution was continuously oxygenated with a gas mixture of 95 % O 2 plus 5 % CO 2 and kept at 37°C (pH 7.4). The bath solution volume was 5 ml. If not otherwise indicated, the vessels were precontracted by serotonin using a concentration producing 30-50 % of KCl (120 mmol/L) contraction. Dilator substances were applied only after precontraction reached a steady-state that was not different between vessels to be compared. In some arterial rings the endothelial layer was mechanically disrupted by gently rubbing the luminal surface of a ring back and forth several times with a whisker. Endothelium integrity or functional removal was confirmed by the presence or absence, respectively, of the relaxant response to 1 µM acetylcholine on serotonin-precontracted arteries 4 . All test compounds were applied by adding to the bath solution. For the desired comparison of the serotonin concentration-response curves, baseline tension was subtracted. Whenever concentration-response curves were to be compared, they were conducted at the same time in adjacent chambers of the myograph in order to control for time dependent changes in contractility. In pilot experiments, concentrations of vehicle substances were determined not having an effect on their own.
RT-PCR
Total RNA was isolated using the "RNeasy Mini-Kit" (Quiagen) with the following changes in the protocol. After isolation, vessel segments without fat were transferred into 1.5 ml test tubes containing 500 µl glass beads (Ø 500 µm) and 500 µl RLT buffer (Quiagen, RNeasyMini-Kit). The tissue specimen were agitated by shaking for 4 min in a tissue disruptor (Scientific Industries) at room temperature. Beads and disrupted tissues were collected by adding further 590 µl RNase-free H 2 O. This suspension was cleared on a spin column (Costar) by centrifugation. From remaining solution total RNA was isolated following the protocol of the manufacturer. In the final step the RNA was collected from the affinity column using 25 µl H 2 O, which was passed twice over the column. The resulting RNA preparation was checked for purity using a "nano-drop photometer" (PQ-Lab). A total amount of 150ng RNA each was reverse transcribed using the "High capacity Reverse Transcription Kit" (Applied Biosystems) with random primers, following the protocol of the manufacturer. Aliquots 2 µl of the resulting 20 µl of cDNA were used for the qRT-PCR using the "SYBR ® Green Jump start Taq ready Mix" (Sigma) running 45 cycles after an initial 94 °C 120 seconds with 94 °C, 15 seconds, 60 °C, 60 seconds. After performing an optimization series for each primer pair, a final concentration of 125 nM each was used. PCR efficiency was evaluated in separate sets of dilution experiments and revealed values between 1.80 and 2.00. Finally, melting curves were recorded and showed a single PCR product for each primer pair.
For comparison of channel expression between SHR and Wistar rats the ∆∆-method was used 5 including an iteration n=2000 as bootstrap. Data were analyzed and illustrated as boxplots using the computer-program "REST-2009" (Corbet Research Pty Ltd, Quiagen-group). For demonstration of channel expression within Wistar rats SYBR-green values of the individual KCNQ channel were normalized to GAPDH using the following equation: Expression = (efficiency of reference) (Cp of reference) /(efficiency of target) (Cp of target) with Cp = first cycle above back ground. The following primers were used:
A piece of a Gracilis artery was placed into a microtube containing 1 mL of an isolation solution containing (in mmol/L): 55 NaCl, 6 KCl, 88 Na glutamate, 2 MgCl 2 , 10 HEPES, 10 glucose, pH 7.4, as well as 0.6 mg/mL papain, and 1.2 mg/mL DL-dithiothreitol for 20 minutes at 37 o C. Then, the artery was transferred into a microtube containing 1 mL of the isolation solution supplemented with 1.2 mg/mL collagenase F, 1.0 mg/mL trypsin inhibitor, and 0.5 mg/mL elastase for 12 minutes at 37 
CHO cell culture
The KCNA5 gene was cloned into the multicloning site of IGAMI vector pAG_STZ (Steinbeis Transferzentrum Angewandte Biologische Chemie, Mannheim) using NheI and NotI restriction sites resulting in the vector pSTZ_Kv1.5. CHO cells (CHO-K1) were grown in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum, 20 mmol/L L-glutamine, 100 U/mL penicillin, and 100 U/mL streptomycin. Cells were cultured at 37 °C and 5% CO 2 . Cells were plated at a density of 8×10 4 cells/well to 2×10 5 cells/well in 24-well plates. 24 hours later cells were transfected using Fugene6 (Promega) according to manufacturer's instructions. After 12 h, medium was replaced with medium containing 0.6 mg/ml G418 (Invivogen). 8 days selection pressure resulted in emerging resistant polyclonal cell populations. For getting single clones, cells were seeded in tissue culture dishes cells per 60x15 mm dish). After one week cultivation single clone colonies were transferred into 49 well plates. Screened best clones were subcloned once again.
Patch-clamp recording
All experiments were performed at room temperature in the whole-cell mode. Patch pipettes had resistances of 2-5 MOhm. The recordings were made with an Axopatch 200 amplifier. Stimulation of currents and data analysis were done with the software package ISO2. KCNQ currents were isolated with a similar protocol as suggested previously (depolarized holding potential (0 mV), 5 sec voltage steps) 6;7 . To reduce the contribution of BK channels, 10 -7 mol/L iberiotoxin, a specific inhibitor of these channels, was added to the bath solution. Initial experiments had shown that neither 1 µmol/L glibenclamide, an inhibitor of ATP-sensitive potassium channels, nor 10 µmol/L barium, an inhibitor of inward rectifying potassium channels, produced any effect on the outward current of these cells.
Blood pressure measurements
We performed radiotelemetry on adult male C57Bl6 and NZO mice (34 weeks) as outlined elsewhere 8 . TA11PA-C20 BP devices (Data Sciences International, St. Paul, MN, USA) were implanted in mice to follow blood pressure and heart rate changes continuously over time. The 3.4 g transmitter unit was calibrated before surgery. Mice were anesthetized by isoflurane (CuraMed Pharma GmbH, Karlsruhe, Germany). Then, the pressure-sensing catheter of the TA11PA-C20 device was carefully moved through the right femoral artery into the abdominal aorta. The transmitter was placed in a subcutaneous pocket along the right flank. All animals were kept in single cages with free access to standard chow and drinking water ad libitum in a room with a 12:12 light dark cycle. The data was collected every 5 min for 10 sec continuously day and night using the DATAQUEST software (A.R.T. 2.1, Data Sciences International) via RPC-1 receivers placed under the mouse cages. After 10 days, mice had recovered from surgery and exhibited regular diurnal rhythms of activity. Systolic blood pressure, diastolic blood pressure, mean arterial blood pressure (MAP), and heart rate (HR) recordings were obtained for 3 days (baseline values) and continued thereafter. 1 hour before and 1 hour after drug application the data were collected and analyzed continuously. Mice received vehicle (control), retigabine, VRX0621688 and VRX0530727 (15 mg/kg each i.p.). The time period intervening the application of different drugs averaged 48 h. Systolic blood pressure in rats was measured using standard tail-cuff methodology 9;10 . Briefly, animals were conditioned to the measurement procedure for several days before the actual experiment. Vasodilation was achieved using a heat lamp. The results of 3-10 successful measurements in a recording session were averaged. Rats received vehicle (control), retigabine or VRX0621688 (9 mg/kg i.p.), respectively. Measurements were performed 1, 4, and 6 hours after drug application. The change in systolic blood pressure was calculated as the difference of the blood pressure 1 hour after application of the KCNQ channel activator and the blood pressure 1 hour after application of vehicle in a time matched fashion.
Materials and statistics
Retigabine, VRX0530727, VRX0621238 (ICA-27243), and VRX0621688 were provided by Valeant Research North America (Aliso Viejo, California 92656) 11 . XE991 was purchased from Ascent Scientific (Bristol, UK) or Tocris (Bristol, UK). Serotonin, U44619, phenylephrine, 4-aminopyridine, glibenclamide and tetraethylammonium were from SigmaAldrich (Germany). Apamine and stromatoxin were from Alomone (Jerusalem, Israel). All values are given as mean ± SEM. Statistics: Two concentration-response curves or two current-voltage relationships were compared using repeated measures ANOVA based on all data points. The concentration-response relationship for XE991 obtained in the patch-clamp experiments was evaluated using one-way ANOVA based on all data points. All other data were compared using paired and unpaired Student' s t tests as appropriate. A value of p <0.05 was considered statistically significant; n represents the number of arteries tested.
Results
The anti-contractile effect of fat was also observed in the presence of (i) 1 µmol/L glibenclamide, a specific inhibitor of ATP-sensitive potassium channels (n=6) ( Figure S2B ), (ii) 1 mmol/L tetraethylammonium (TEA), a specific inhibitor of large-conductance calciumactivated potassium (BK) channels at this concentration, (n=5) (Fig. S2C) , and (iii) 1 µmol/L apamin, a specific inhibitor of small conductance calcium-activated potassium (SK) channels, (n=5) ( Figure S2D ).
RT-PCR in intact rat mesenteric arteries showed reduced expression of KCNQ4 in SHR compared to age-matched Wistar rats (n=7-8) (Fig. S5) , an effect not observed in the same series of experiments for Gracilis artery KCNQ4 channels. 
